autologous chondrocyte tissue-engineered cartilage

Autologous chondrocyte tissue-engineered cartilage is an investigational cell therapy and tissue engineering product developed by the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine. The therapy involves harvesting a patient's own chondrocytes, expanding them in vitro, and formulating them into an injectable construct—often utilizing a scaffold or hydrogel carrier—to regenerate functional cartilage tissue at the site of implantation. This approach is primarily being explored for the correction of anatomical defects, such as nasal floor and base depressions in patients with postoperative deformities of cleft lip and palate, where it aims to provide structural support and aesthetic restoration through biological tissue regeneration.

Other names

autologous tissue-engineered injectable cartilageinjectable cartilage regenerated from autologous chondrocytes